Vliyanie lipektomii peredney stenkizhivota na techenie metabolicheskogosindroma

Summary. Objective: to study the influence of surgical correction of abdominal obesity in patients with type 2 diabetes mellitus on clinical course of metabolic syndrome (MS). Design and methods: 181obesity and type 2 diabetes mellitus patients were studied. All patients were divided into two groups...

Full description

Bibliographic Details
Main Authors: Mariya Aleksandrovna Volokh, Yuriy Shavkatovich Khalimov, Vladimir Mikhaylovich Shapovalov, Nikolay Grigor'evich Gubochkin
Format: Article
Language:English
Published: Concilium Medicum 2011-03-01
Series:КардиоСоматика
Subjects:
Online Access:https://cardiosomatics.orscience.ru/2221-7185/article/view/44964
Description
Summary:Summary. Objective: to study the influence of surgical correction of abdominal obesity in patients with type 2 diabetes mellitus on clinical course of metabolic syndrome (MS). Design and methods: 181obesity and type 2 diabetes mellitus patients were studied. All patients were divided into two groups. First group consisted of 109 patients, who underwent lipoaspiration or abdominoplasty with subsequent medication. Second group - 72 patients suffering from abdominal obesity and type 2 diabetes mellitus, were treated conservatively without surgery. MS was diagnosed by six criteria in 90 (82,5%) first group patients and in 57 (79,1%) second group patients. 19 (17,5%) patients in the first group and 15 (20,9%) - in the second had five diagnostic MS criteria. Results. The study of patients serum lipid structure shows different results depending on the treatment technique. Anterior abdominal wall lipectomy leads to much faster and significant improvement in main lipidogram features, especially triglyceride and low-density lipoprotein concentration, which are the most important markers of MS progression. Unlike patients with obesity and type 2 diabetes mellitus treated conservatively with medication, surgically treated patients show fast and resistant improvement in cardonhydrate metabolism compensation markers, which are decrease of serum fasting glucose and glycated hemoglobin levels. Arterial hypertension stage II and III in the first group patients developed significantly less in 5 years after surgery (р
ISSN:2221-7185
2658-5707